Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1) von Mañós, M, Giralt, J, Rueda, A, Cabrera, J, Martinez-Trufero, J, Marruecos, J, Lopez-Pousa, A, Rodrigo, J.P, Castelo, B, Martínez-Galán, J, Arias, F, Chaves, M, Herranz, J.J, Arrazubi, V, Baste, N, Castro, A, Mesía, R

Volltext

PKCε upregulates voltage-dependent calcium channels in cultured astrocytes von Burgos, M., Pastor, M. D., González, J. C., Martinez-Galan, J. R., Vaquero, C. F., Fradejas, N., Benavides, A., Hernández-Guijo, J. M., Tranque, P., Calvo, S.

Volltext

136 Methylation ESR1as potencial factor of resistence to Her2/neu therapy in breast cancer patients von Martinez-Galan, J, Ochoa, L, Amezcua, V, Delgado, J.R

Volltext

MC13-0090 Epigenetic silencing promotor gene of ESR1 in DNA circulating and not expression of estrogen receptor in tumors of patients with breast cancer von Martinez-Galan, J, Delgado, J.R, Del Moral, R, Torres-Torres, B, Ríos, S

Volltext

444 DNA Methylation-Based as a Prediction of Therapeutic Outcome in Serum of Patients with Breast Cancer von Martinez-Galan, J, Delgado, J.R, Torres-Torres, B, López-Peñalver, J, Del Moral, R, de Almodóvar, M. Ruiz

Volltext

292 Relation Between CpG Methylation 14-3-3-sigma and Nodal Positive Status in Breast Cancers von Martinez-Galan, J, Perez, J.R. Delgado, Ballesteros, P, Lopez-Penalver, J, Rís-Arrabal, S, Nunez-Torres, M.I

Volltext

Different origins and developmental histories of transient neurons in the marginal zone of the fetal and neonatal rat cortex von Meyer, Gundela, Soria, José Miguel, Martínez-Galán, Juan Ramón, Martín-Clemente, Begoña, Fairén, Alfonso

Volltext

1120 POSTER Hypermethylation of Tumour Suppressor Gene 14-3-3sigma in Serum of Sporadic Breast Cancer Patients von Martinez-Galan, J, Perez, J.R. Delgado, Ortega, J.A, Del Moral Ávila, R, Torres, B. Torres, Ríos-Arrabal, S, García-García, J, Soberino, J, González-Rivas, C, Núñez, M.I

Volltext

6593 POSTER Phase II Trial of MiniDOX in “Suboptimal” Patients With Advanced Gastric Cancer (AGC). TTD 08-02 (N° EudraCT: 2008-001825-32) von Rivera, F, Massuti, B, López-López, C, Sastre, J, Galán, J. Martínez, Valladares-Ayerbes, M, Gómez, A, Manzano, J.L, Galón, M, Aranda, E

Volltext

941TiP A phase I/IIa, open-label, dose-finding trial to evaluate safety, immunogenicity, and anti-tumour activity of VB10.16 in combination with pembrolizumab in patients with unre... von Khalique, S., Oliva, M., Even, C., Dziadziuszko, R., Dietz, A., Italiano, A., Melichar, B., Martinez-Galan, J., Brydøy, M., Thouvenin, J., Rutkowski, T., Hitre, E., Guix Arnau, M., Lopez Criado, M.P., Jürgens, T., Bratland, Å.

Volltext

1542P Untargeted metabolomics to identify novel biomarkers of pancreatic cancer von Caba, O., Jimenez-Luna, C., Martin-Blazquez, A., Martinez-Galan, J., Perez Del Palacio, J., Melguizo, C., Diaz, C., Dieguez, C., Vicente, F., Genilloud, O., Martin-Ruiz, J.L., Prados, J.

Volltext

Pancreatic ductal adenocarcinoma: metastatic disease von Muñoz Martín, A. J., Adeva, J., Martínez-Galán, J., Reina, J. J., Hidalgo, M.

Volltext

Phase II trial of miniDOX (reduced dose docetaxel–oxaliplatin–capecitabine) in “suboptimal” patients with advanced gastric cancer (AGC). TTD 08-02 von Rivera, F., Massutí, B., Salcedo, M., Sastre, J., Martínez Galán, J., Valladares-Ayerbes, M., Serrano, R., de Paredes, Mª. L. García, Manzano, J. L., Galán, M., Alsina, M., Yuste Izquierdo, A. L., López, C., Díaz-Rubio, E., Conde, V., Reboredo, M., Cano, Mª. T., Pachón, V., Aranda, E.

Volltext

45PMETHYLATION OF DNA FREE IN BLOOD SAMPLE AS PROGNOSTIC FACTOR IN BREAST CANCER SUBTYPE von Martinez-Galan, J., González-Rivas, C., Delgado, J.R.

Volltext

176 Relation between methylation promoters gene and estrogen receptor (ERS1) and her2/neu status in breast cancer patients von Martinez-Galan, J, Torres, B. Torres, Del Moral Ávila, R, Bautista, J. Valdivia, Torres, M.I. Nuñez, Rubio, V. Castellon, Vicente, A. Gonzalez, Garcia, J. Soberino, Perez, J.R. Delgado, De Almodovar, M. Ruiz

Volltext

Modification of Methylation Level Dna Promoter in Serum of a Panel of Gene Before and After Treatment and Impact in Prognostic Factor in Patients with Breast Cancer von Martinez-Galan, J., Gonzalez-Rivas, C., Vozmediano, J. Ruiz, Castillo, L., Ochoa, L., Delgado, J.R.

Volltext

170PMODIFICATION OF METHYLATION LEVEL DNA PROMOTER IN SERUM OF A PANEL OF GENE BEFORE AND AFTER TREATMENT AND IMPACT IN PROGNOSTIC FACTOR IN PATIENTS WITH BREAST CANCER von Martinez-Galan, J., Gonzalez-Rivas, C., Vozmediano, J. Ruiz, Castillo, L., Ochoa, L., Delgado, J.R.

Volltext

544 DNA methylation: an epigenetic pathway to cancer and a promising target for anticancer therapy in breast cancer von Martinez-Galan, J, Delgado, J.R, Del Moral Ávila, R, Torres Torres, B, Nuñez, M.I, Valdivia, J, Luque, R, Peñalver, J, Ríos-Arrabal, S, Ruiz De Almodovar, M

Volltext

Methylation of DNA Free in Blood Sample as Prognostic Factor in Breast Cancer Subtype von Martinez-Galan, J., González-Rivas, C., Delgado, J.R.

Volltext

PP106 DNA promoter methylation in breast cancer as possible biomarkers for screening breast cancer and association with molecular breast cancer subtypes von Martinez-Galan, J, Torres-Torres, B, Del Moral, R, Conde, V, Luque, R, Valdivia, J, Nunez, M.I, Villalobos, M, Delgado, J.R, de Almodovar, M. Ruiz

Volltext